CY1122343T1 - Μεθοδοι για την κατασκευη παραγωγων ινδαζολιου - Google Patents
Μεθοδοι για την κατασκευη παραγωγων ινδαζολιουInfo
- Publication number
- CY1122343T1 CY1122343T1 CY20191101273T CY191101273T CY1122343T1 CY 1122343 T1 CY1122343 T1 CY 1122343T1 CY 20191101273 T CY20191101273 T CY 20191101273T CY 191101273 T CY191101273 T CY 191101273T CY 1122343 T1 CY1122343 T1 CY 1122343T1
- Authority
- CY
- Cyprus
- Prior art keywords
- methods
- manufacture
- indazole derivatives
- new
- indazole
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical class C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Catalysts (AREA)
Abstract
Η παρούσα εφεύρεση παρέχει νέες μεθόδους για παρασκευή ενώσεων του τύπου (IV) και αλάτων αυτών, νέα ενδιάμεσα και νέο άλας και πολύμορφο αυτού.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1509492.3A GB201509492D0 (en) | 2015-06-02 | 2015-06-02 | Novel processes |
| PCT/EP2016/062250 WO2016193255A1 (en) | 2015-06-02 | 2016-05-31 | Processes to make indazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1122343T1 true CY1122343T1 (el) | 2021-01-27 |
Family
ID=53677608
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20191101273T CY1122343T1 (el) | 2015-06-02 | 2019-12-04 | Μεθοδοι για την κατασκευη παραγωγων ινδαζολιου |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US10266525B2 (el) |
| EP (1) | EP3303329B1 (el) |
| JP (1) | JP6389967B2 (el) |
| KR (1) | KR20180011115A (el) |
| CN (1) | CN107660204B (el) |
| AU (1) | AU2016273752B2 (el) |
| BR (1) | BR112017023486B1 (el) |
| CA (1) | CA2983966A1 (el) |
| CY (1) | CY1122343T1 (el) |
| DK (1) | DK3303329T3 (el) |
| ES (1) | ES2760571T3 (el) |
| GB (1) | GB201509492D0 (el) |
| HR (1) | HRP20192117T1 (el) |
| HU (1) | HUE047523T2 (el) |
| ME (1) | ME03653B (el) |
| PL (1) | PL3303329T3 (el) |
| PT (1) | PT3303329T (el) |
| RS (1) | RS59639B1 (el) |
| RU (1) | RU2017134467A (el) |
| SI (1) | SI3303329T1 (el) |
| SM (1) | SMT201900705T1 (el) |
| WO (1) | WO2016193255A1 (el) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2644724T3 (es) * | 2009-04-30 | 2017-11-30 | Glaxo Group Limited | Indazoles sustituidos con oxazol como inhibidores de PI3-cinasas |
| HUE026059T2 (en) * | 2010-09-08 | 2016-05-30 | Glaxosmithkline Ip Dev Ltd | N- [5- [4- (5 - {[(2R, 6S) -2,6-dimethyl-4-morpholinyl] methyl} -1,3-oxazol-2-yl) -1H-indazol-6-yl ] Polymorphs and salts of 2 - (methyloxy) -3-pyridinyl] methanesulfonamide |
| JP5876051B2 (ja) * | 2010-09-08 | 2016-03-02 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | インフルエンザウィルス感染の治療に使用するためのインダゾール誘導体 |
| GB201018124D0 (en) * | 2010-10-27 | 2010-12-08 | Glaxo Group Ltd | Polymorphs and salts |
| US20160263109A1 (en) | 2013-10-17 | 2016-09-15 | Glaxosmithkline Intellectual Property Development Limited | P13k inhibitor for treatment of respiratory disease |
-
2015
- 2015-06-02 GB GBGB1509492.3A patent/GB201509492D0/en not_active Ceased
-
2016
- 2016-05-31 DK DK16726309T patent/DK3303329T3/da active
- 2016-05-31 BR BR112017023486-6A patent/BR112017023486B1/pt active IP Right Grant
- 2016-05-31 CN CN201680029002.0A patent/CN107660204B/zh active Active
- 2016-05-31 RU RU2017134467A patent/RU2017134467A/ru not_active Application Discontinuation
- 2016-05-31 KR KR1020177033696A patent/KR20180011115A/ko not_active Withdrawn
- 2016-05-31 AU AU2016273752A patent/AU2016273752B2/en not_active Ceased
- 2016-05-31 SI SI201630555T patent/SI3303329T1/sl unknown
- 2016-05-31 SM SM20190705T patent/SMT201900705T1/it unknown
- 2016-05-31 CA CA2983966A patent/CA2983966A1/en not_active Abandoned
- 2016-05-31 HU HUE16726309A patent/HUE047523T2/hu unknown
- 2016-05-31 RS RS20191554A patent/RS59639B1/sr unknown
- 2016-05-31 WO PCT/EP2016/062250 patent/WO2016193255A1/en not_active Ceased
- 2016-05-31 US US15/578,258 patent/US10266525B2/en active Active
- 2016-05-31 ES ES16726309T patent/ES2760571T3/es active Active
- 2016-05-31 EP EP16726309.4A patent/EP3303329B1/en active Active
- 2016-05-31 PT PT167263094T patent/PT3303329T/pt unknown
- 2016-05-31 PL PL16726309T patent/PL3303329T3/pl unknown
- 2016-05-31 HR HRP20192117TT patent/HRP20192117T1/hr unknown
- 2016-05-31 JP JP2017562313A patent/JP6389967B2/ja active Active
- 2016-05-31 ME MEP-2019-326A patent/ME03653B/me unknown
-
2019
- 2019-12-04 CY CY20191101273T patent/CY1122343T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL3303329T3 (pl) | 2020-03-31 |
| US20180155334A1 (en) | 2018-06-07 |
| SI3303329T1 (sl) | 2020-02-28 |
| GB201509492D0 (en) | 2015-07-15 |
| KR20180011115A (ko) | 2018-01-31 |
| JP6389967B2 (ja) | 2018-09-12 |
| HRP20192117T1 (hr) | 2020-02-21 |
| EP3303329A1 (en) | 2018-04-11 |
| ME03653B (me) | 2020-07-20 |
| WO2016193255A1 (en) | 2016-12-08 |
| BR112017023486B1 (pt) | 2023-02-14 |
| SMT201900705T1 (it) | 2020-01-14 |
| DK3303329T3 (da) | 2019-12-02 |
| RU2017134467A (ru) | 2019-07-15 |
| BR112017023486A2 (pt) | 2018-07-24 |
| AU2016273752A1 (en) | 2017-10-19 |
| RU2017134467A3 (el) | 2019-10-11 |
| RS59639B1 (sr) | 2020-01-31 |
| AU2016273752B2 (en) | 2018-07-05 |
| ES2760571T3 (es) | 2020-05-14 |
| US10266525B2 (en) | 2019-04-23 |
| JP2018518477A (ja) | 2018-07-12 |
| HUE047523T2 (hu) | 2020-04-28 |
| EP3303329B1 (en) | 2019-09-18 |
| CN107660204B (zh) | 2021-04-13 |
| CN107660204A (zh) | 2018-02-02 |
| CA2983966A1 (en) | 2016-12-08 |
| PT3303329T (pt) | 2019-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201790407A1 (ru) | Зонды для визуализации белка хантингтина | |
| EA201591634A1 (ru) | Дигидропиридопиримидиновые соединения | |
| CR20160098A (es) | Polimorfo de los inhibidores de la syk | |
| BR112017006253A2 (pt) | novos compostos | |
| MX2017001980A (es) | Derivado de quinolina muy puro y metodo para su produccion. | |
| EA201791684A1 (ru) | Селективные ингибиторы bace1 | |
| MX384201B (es) | Proceso para la preparacion de treprostinil. | |
| EA201890899A1 (ru) | Модуляторы фарнезоидного x-рецептора | |
| JOP20170100B1 (ar) | توليف مركبات إندازول | |
| CY1124251T1 (el) | Παραγωγα καρβοξαμιδιου | |
| UA122882C2 (uk) | Синтез індазолів | |
| EA202090368A1 (ru) | Соединения-ингибиторы рецептора лизофосфатидной кислоты 1 (lpar1) | |
| MX375638B (es) | Proceso para la fabricación de medicamentos. | |
| EA201790408A1 (ru) | Зонды для визуализации белка хантингтина | |
| MX387796B (es) | Compuestos de aminocarbonilcarbamato. | |
| EA201790982A1 (ru) | Синтез копанлисиба и его дигидрохлорида | |
| EA201790400A1 (ru) | Зонды для визуализации белка хантингтина | |
| EA201591915A1 (ru) | Соединения феноксиэтил дигидро-1h-изохинолина | |
| CL2018001067A1 (es) | Compuesto piranodipiridínico. | |
| CY1120763T1 (el) | Νεες ενωσεις σουλφονυλαμινοβενζαμιδιου | |
| HUE054815T2 (hu) | 3,5-Difenil-diazol vegyületek vízoldható származékai | |
| EA201791645A1 (ru) | Новые соли и полиморфы scy-078 | |
| EA201990313A1 (ru) | Производное триазолопиразинона, пригодное в качестве ингибитора фдэ1 человека | |
| CY1121116T1 (el) | Νεα μεθοδος για την συνθεση αγομελατινης | |
| MX2019001228A (es) | Metodo de produccion del compuesto de pirazol-amida. |